Meanwell Clive

Avg. Two Year Performance

(45%) Avg. Purchase Return
(20%) Compound
(18%) Avg. Sale Return
(9%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return12%27%25%59%(45%)
Purchase Success Rate1 of 11 of 11 of 11 of 10 of 1
Average Sale Return< 1%5%3%4%(18%)
Sale Success Rate20 of 4416 of 4414 of 4416 of 4414 of 44
Drugs » Drug Manufacturers - Other

Chief Innovation Officer, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chief Executive Officer, Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Other

Director:

Holdings: 11.86K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 277.89K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--